Eterna Therapeutics Inc (ERNA) Live Share Price, Invest From India

Eterna Therapeutics Inc Stock Performance

as on December 8, 2025 at 11:26 pm IST

Day's Low
Day's High
$1.25
Day's Price Range
$1.3
$1.28
2.34%
Downside
1.56%
Upside
52 Week's Low
52 Week's High
$1.09
52-Week Price Range
$14.4
$1.28
14.84%
Downside
1025.00%
Upside

Eterna Therapeutics Inc share price movements today

Previous Close: $1.32
Open: $1.29
Volume: 120.5K
Day's Low - High: $1.25 - $1.3
52 Week Low - High: $1.09 - $14.4

Eterna Therapeutics Inc Historical Returns

1 Month Return: -24.57 %
3 Month Return: + 6.45 %
1 Year Return: -77.99 %
3 Year Return: -98.2 %
5 Year Return: 0 %

Eterna Therapeutics Inc Stock Fundamentals & Key Indicators

Check Eterna Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$10.4M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0.02

Industry PE ratio

PEG Ratio

EBITDA

-9.9M

Revenue (TTM)

1.0K

Profit Margin

0.00%

Return On Equity TTM

-2264.31%

Eterna Therapeutics Inc Stock Valuation

Track how Eterna Therapeutics Inc P/E has moved over time to understand its valuation trends.

Eterna Therapeutics Inc in the last 5 years

Overview
Trends

Lowest (-9.75x)

March 31, 2023

Industry (0.00x)

December 8, 2025

Today (0.02x)

December 8, 2025

Highest (-0.70x)

June 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 0.02x

Eterna Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Eterna Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Eterna Therapeutics Inc	SELL	$10.4M	NA	0.02	0.00%
Insmed Incorporated	BUY	$43.5B	418.42%	-16.34	-264.83%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	257.77%	1431.62	1.36%
Vertex Pharmaceuticals Incorporated	BUY	$116.8B	98.18%	32.05	31.35%
Regeneron Pharmaceuticals, Inc.	BUY	$76.1B	44.5%	17.21	32.13%

Stock Returns calculator for Eterna Therapeutics Inc Stock including INR - Dollar returns

The Eterna Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Eterna Therapeutics Inc investment value today

Current value as on today

₹27,473

Returns

₹72,527

(-72.53%)

Returns from Eterna Therapeutics Inc Stock

₹78,667 (-78.67%)

Dollar Returns*

₹6,139 (+6.14%)

Analyst Recommendation on Eterna Therapeutics Inc Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Eterna Therapeutics Inc. Average target price of $3

Eterna Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Eterna Therapeutics Inc.

What analysts predicted

57.33%UPSIDE

Target Price

Current Price

$1.28

Analyzed by

6 Analysts

Target

$3.00

Eterna Therapeutics Inc target price $3, a slight upside of 57.33% compared to current price of $1.28. According to 6 analysts rating.

Eterna Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Eterna Therapeutics Inc Stock has decreased by -67% in the last 30 days, reflecting a downward trend in search activity.

Time period: November 8, 2025 to December 8, 2025

Change:-67% versus previous 30 day period

Eterna Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	-	0	0	0	0	0	0	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	-
Operating Income	-4	-5	-5	-5	-4	-2	-2	-2	-2	-1
EBITDA	-4	-4	-5	-5	-4	-24	-2	-2	-2	-1
Interest Expense	-	0	0	0	0	1	3	0	-	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-4	-5	-6	-6	-5	-26	-5	-8	-3	-1
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-4	-5	-6	-6	-5	-26	-5	-8	-3	-1
Net Profit Margin	0.00%	-10962.75%	-36194.12%	-14142.55%	-11763.83%	-5462.83%	-575900.00%	0.00%	0.00%	0.00%

Eterna Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	24	22	21	23	19	5	-	-	0	0
Gross Profit	11	14	14	14	11	0	0	0	0	0
Operating Income	-6	-2	-1	0	-1	-7	-113	-33	-21	-15
EBITDA	-3	0	0	3	1	-26	-121	-24	-19	-36
Interest Expense	0	0	0	0	0	0	0	0	0	6
Depreciation	-	-	-	-	-	0	0	0	0	1
Income Before Tax	-7	-2	-1	0	-2	-26	-122	-24	-21	-44
Income Tax Expense	0	0	0	0	0	-19	0	0	0	0
Net Income	-7	-2	-1	0	-2	11	-122	-24	-21	-44
Net Profit Margin	-29.47%	-13.10%	-5.06%	-1.11%	-10.34%	205.28%	0.00%	0.00%	-31864.71%	-7652.75%

Eterna Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-5	-6	-6	-5	-26	-5	-8	-3	-1
Operating Cash Flow	-5	-4	-3	-2	-6	-3	-2	-2	-1
Investing Cash Flow	-	0	0	0	0	-	-	-	0
Financing Cash Flow	8	7	1	0	3	1	2	4	0
Change in Cash	2	3	-2	-2	1	-2	0	2	-1

Eterna Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-2	-1	0	-2	-26	-122	-24	-21	-44
Operating Cash Flow	0	0	1	2	-8	-23	-20	-20	-15
Investing Cash Flow	0	-1	-1	-1	0	-22	0	0	0
Financing Cash Flow	3	-1	0	-1	4	61	19	16	6
Change in Cash	2	-2	0	0	-1	15	-1	-3	-9

Global Institutional Holdings in Eterna Therapeutics Inc

Funds	Holdings
Geode Capital Management, LLC	0.26%
CI Private Wealth LLC	0.23%
Sippican Capital Adivsors	0.13%
BlackRock Inc	0.01%
Morgan Stanley - Brokerage Accounts	0.01%

See all

Insights on Eterna Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 170.6% return, outperforming this stock by 248.6%
NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 995.0% return, outperforming this stock by 1093.2%
NEGATIVE IMPACT
Price Dip
In the last 1 month, ERNA stock has moved down by -24.6%

About Eterna Therapeutics Inc

brooklyn is focused on exploring the role that cytokine, gene editing, and cell therapy can have in treating patients with cancer, blood disorders, and monogenic diseases. brooklyn’s most advanced program is irx-2, a human cell-derived cytokine therapy, studying the safety and efficacy of irx-2 in patients with head and neck cancer in phase 2b. in a phase 2a clinical trial in head and neck cancer, irx-2 demonstrated an overall survival benefit. additional studies are either underway or planned in other solid tumor cancer indications. brooklyn has multiple next-generation cell and gene-editing therapies in preclinical development for various indications including acute respiratory distress syndrome, solid tumor indications, as well as in vivo gene-editing therapies for rare genetic diseases. for more information about brooklyn and its clinical programs, please visit www.brooklynitx.com.

Organisation	Eterna Therapeutics Inc
Headquarters	1035 Cambridge Street, Cambridge, MA, United States, 02141
Industry	Healthcare
CEO	Mr. Sanjeev Luther
E-voting on shares	Click here to vote

Key Management of Eterna Therapeutics Inc

Name	Title
Mr. Sanjeev Luther	CEO, President & Director
Ms. Sandra M. Gurrola	Principal Financial & Accounting Officer and Senior VP of Finance
Ms. Dorothy J. Clarke	General Counsel
Dr. Robert Hamilton Pierce M.D.	Chief Scientific Officer

FAQs

What is Eterna Therapeutics Inc share price today?

Eterna Therapeutics Inc share price today is $1.28 as on December 8, 2025 at 11:26 pm IST. Eterna Therapeutics Inc share today touched a day high of $1.3 and a low of $1.25.

What is the 52 week high and 52 week low for Eterna Therapeutics Inc share?

Eterna Therapeutics Inc share touched a 52 week high of $14.4 on January 14, 2025 and a 52 week low of $1.09 on September 30, 2025. Eterna Therapeutics Inc stock price today i.e. December 8, 2025 at 11:26 pm IST is trending at $1.28,which is 91.11% down from its 52 week high and 17.43% up from its 52 week low.

What is Eterna Therapeutics Inc's market capitalisation today?

Eterna Therapeutics Inc market capitalisation is $0.00T as on December 8, 2025 at 11:26 pm IST.

How to invest in Eterna Therapeutics Inc Stock (ERNA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Eterna Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Eterna Therapeutics Inc Shares that will get you 1.1719 shares as per Eterna Therapeutics Inc share price of $1.28 per share as on December 8, 2025 at 11:26 pm IST.

What is the minimum amount required to buy Eterna Therapeutics Inc Stock (ERNA) from India?

Indian investors can start investing in Eterna Therapeutics Inc (ERNA) shares with as little as ₹90.066 or $1 (as of December 8, 2025 at 11:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹900.66 in Eterna Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on December 8, 2025 at 11:42 pm IST). Based on Eterna Therapeutics Inc share’s latest price of $1.28 as on December 8, 2025 at 11:26 pm IST, you will get 7.8125 shares of Eterna Therapeutics Inc. Learn more about fractional shares .